PML RARA T1517Q22Q12 Gene Rearrangement Quantitative MRD Monitor Test
The PML RARA T1517Q22Q12 Gene Rearrangement Quantitative MRD Monitor Test is an advanced diagnostic tool used primarily in the field of hematology to monitor minimal residual disease (MRD) in patients with certain types of cancer, particularly acute promyelocytic leukemia (APL). This test is crucial for evaluating the effectiveness of treatment and for early detection of relapse.
What the Test Measures/Detects
This test measures the presence of specific gene rearrangements associated with APL, allowing healthcare providers to quantify the level of residual disease after treatment. By detecting these genetic markers, clinicians can make informed decisions regarding ongoing treatment and management strategies.
Who Should Consider This Test
- Patients diagnosed with acute promyelocytic leukemia (APL).
- Individuals experiencing symptoms such as unexplained bleeding, fatigue, or frequent infections.
- Patients at high risk for relapse or those undergoing treatment for APL.
Benefits of Taking the Test
- Provides critical information on treatment effectiveness.
- Helps in the early detection of relapse, enabling timely intervention.
- Guides clinicians in making personalized treatment decisions.
Understanding Your Results
Results from the PML RARA T1517Q22Q12 Gene Rearrangement Quantitative MRD Monitor Test will indicate the level of residual disease in the patient’s system. A lower level of residual disease typically suggests a better response to treatment. It is essential to discuss your results with your healthcare provider to understand their implications fully.
Test Details and Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| PML RARA T1517Q22Q12 Gene Rearrangement Quantitative MRD Monitor Test | 121680 NGN | 135200 NGN |
How to Book the Test
To book the PML RARA T1517Q22Q12 Gene Rearrangement Quantitative MRD Monitor Test, please call or WhatsApp us at +2348110567037. Our team is ready to assist you with scheduling your test and answering any questions you may have.
Pre-Test Instructions
It is mandatory to submit a duly filled MRD Requisition form (Form 22) with historical data prior to the test. Ensure that the sample type is 5 mL (3 mL min.) whole blood or bone marrow in a lavender top (EDTA) tube. Ship refrigerated and do not freeze.
Turnaround Time
Samples should be submitted on Monday, Wednesday, or Friday by 9 AM, with reports available on Tuesday, Thursday, or Saturday.
Trust DNA Labs Nigeria for accurate and timely diagnostics. Book your test today!
